Abbvie Inc
NYSE:ABBV
Abbvie Inc
Net Change in Cash
Abbvie Inc
Net Change in Cash Peer Comparison
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbvie Inc
NYSE:ABBV
|
Net Change in Cash
$3.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
0%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Change in Cash
$673m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-42%
|
CAGR 10-Years
8%
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Change in Cash
$3.3B
|
CAGR 3-Years
144%
|
CAGR 5-Years
1%
|
CAGR 10-Years
20%
|
|
Moderna Inc
NASDAQ:MRNA
|
Net Change in Cash
-$289m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Change in Cash
-$139.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Change in Cash
-$381.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbvie Inc's Net Change in Cash?
Net Change in Cash
3.6B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Net Change in Cash amounts to 3.6B USD.
What is Abbvie Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
0%